Christopher J. Gibson

12.5k total citations · 5 hit papers
72 papers, 4.2k citations indexed

About

Christopher J. Gibson is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Christopher J. Gibson has authored 72 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 21 papers in Genetics and 16 papers in Oncology. Recurrent topics in Christopher J. Gibson's work include Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Cancer Genomics and Diagnostics (13 papers). Christopher J. Gibson is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Cancer Genomics and Diagnostics (13 papers). Christopher J. Gibson collaborates with scholars based in United States, Sweden and Canada. Christopher J. Gibson's co-authors include Umesh D. Parashar, Roger I. Glass, Joseph Bresee, Benjamin L. Ebert, Adam S. Sperling, Frank C. Detterbeck, Nancy Berliner, David P. Steensma, Matthew S. Davids and Jennifer H. Yearley and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Christopher J. Gibson

71 papers receiving 4.1k citations

Hit Papers

Rotavirus and Severe Childhood Diarrhea 2006 2026 2012 2019 2006 2017 2016 2021 2023 400 800 1.2k

Peers

Christopher J. Gibson
Liu H Taiwan
Owen Smith Ireland
Mahboob U. Rahman United States
D Émilie France
Liu H Taiwan
Christopher J. Gibson
Citations per year, relative to Christopher J. Gibson Christopher J. Gibson (= 1×) peers Liu H

Countries citing papers authored by Christopher J. Gibson

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Gibson more than expected).

Fields of papers citing papers by Christopher J. Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Gibson. The network helps show where Christopher J. Gibson may publish in the future.

Co-authorship network of co-authors of Christopher J. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Gibson. A scholar is included among the top collaborators of Christopher J. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Gibson. Christopher J. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Chengcheng, Melissa A. Richard, Christopher J. Gibson, et al.. (2024). Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Journal of Clinical Oncology. 42(20). 2415–2424. 16 indexed citations
2.
Richard, Melissa A., Chengcheng Yan, Yan-Jun Chen, et al.. (2024). Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms. Journal of Clinical Oncology. 42(31). 3739–3750. 4 indexed citations
3.
Gibson, Christopher J., R. Coleman Lindsley, & Lukasz P. Gondek. (2024). Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Seminars in Hematology. 61(1). 9–15. 3 indexed citations
4.
Kwong, Brandon, Joseph Banuelos, Petro Starokadomskyy, et al.. (2024). POS0462 PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 83. 1129–1130. 2 indexed citations
5.
Gibson, Christopher J., Geoffrey Fell, Tal Sella, et al.. (2023). Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clinical Cancer Research. 29(13). 2551–2558. 15 indexed citations
6.
Vlasschaert, Caitlyn, Taralynn Mack, J. Brett Heimlich, et al.. (2023). A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets. Blood. 141(18). 2214–2223. 74 indexed citations
7.
Robinette, Michelle L., Lachelle D. Weeks, Mridul Agrawal, et al.. (2023). Association of Somatic TET2 Mutations With Giant Cell Arteritis. Arthritis & Rheumatology. 76(3). 438–443. 14 indexed citations
10.
Sella, Tal, Geoffrey Fell, Peter G. Miller, et al.. (2022). Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Advances. 6(24). 6151–6161. 8 indexed citations
11.
Tsai, Harrison, Christopher J. Gibson, H. Moses Murdock, et al.. (2022). Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes. Blood Advances. 6(14). 4236–4240. 7 indexed citations
12.
Tsai, Harrison, Diane Brackett, David Szeto, et al.. (2020). Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms. Journal of Molecular Diagnostics. 22(9). 1162–1178. 13 indexed citations
13.
Gibson, Christopher J. & R. Coleman Lindsley. (2020). Stem cell donors should not be screened for clonal hematopoiesis. Blood Advances. 4(4). 789–792. 24 indexed citations
14.
Myllymäki, Mikko, Robert Redd, Christopher R. Reilly, et al.. (2020). Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome. Blood. 136(26). 3070–3081. 23 indexed citations
15.
Lindsley, R. Coleman, Christopher J. Gibson, H. Moses Murdock, et al.. (2019). Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 15–15. 27 indexed citations
16.
Armenian, Saro H., Christopher J. Gibson, Russell C. Rockne, & Kirsten K. Ness. (2018). Premature Aging in Young Cancer Survivors. JNCI Journal of the National Cancer Institute. 111(3). 226–232. 58 indexed citations
17.
Weinberg, Olga K., Christopher J. Gibson, Traci M. Blonquist, et al.. (2018). Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities. Haematologica. 103(4). 626–633. 18 indexed citations
18.
Yearley, Jennifer H., Christopher J. Gibson, Ni Yu, et al.. (2017). PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer. Clinical Cancer Research. 23(12). 3158–3167. 453 indexed citations breakdown →
19.
Tarhini, Ahmad A., Haris Zahoor, Jennifer H. Yearley, et al.. (2015). Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma. Journal of Translational Medicine. 13(1). 319–319. 27 indexed citations
20.
Gibson, Christopher J., Muhammad M. Hossain, Jason R. Richardson, & Lauren M. Aleksunes. (2012). Inflammatory Regulation of ATP Binding Cassette Efflux Transporter Expression and Function in Microglia. Journal of Pharmacology and Experimental Therapeutics. 343(3). 650–660. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026